105 related articles for article (PubMed ID: 2572266)
1. Effects of xamoterol on sodium excretion in volunteers.
Zech PY; Pozet N; Day MA; Snow HM; Madonna O; Hadj-Aissa A
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):89S-91S. PubMed ID: 2572266
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
[TBL] [Abstract][Full Text] [Related]
3. Effect of xamoterol on peripheral blood vessels in healthy subjects.
Fitzgerald DE
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):70S-72S. PubMed ID: 2572259
[TBL] [Abstract][Full Text] [Related]
4. Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
Ollivier JP; Ricordei I; Bayon P; Popelard P; Moyse D; de Bourayne J; Dupont C; Droniou J
Eur Heart J; 1990 Apr; 11 Suppl A():59-60. PubMed ID: 1971594
[TBL] [Abstract][Full Text] [Related]
5. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
Tangø M; Carlsen JE; Trap-Jensen J
Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
[TBL] [Abstract][Full Text] [Related]
6. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
Rousseau MF; Pouleur H; Debaisieux JC; Van Eyll C; Charlier AA
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264
[TBL] [Abstract][Full Text] [Related]
8. [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Richaud M; Lechat P; Komajda M; Landault C; Fournier P; Fraysse JB; Grosgogeat Y
Arch Mal Coeur Vaiss; 1990 Feb; 83(2):247-52. PubMed ID: 1968739
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
10. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
[No Abstract] [Full Text] [Related]
13. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
McCaffrey PM; Riddell JG; Shanks RG
Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
[TBL] [Abstract][Full Text] [Related]
15. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG
Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
Sørensen EV; Jensen HK; Faergeman O
Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
[TBL] [Abstract][Full Text] [Related]
17. The electrophysiological effects of intravenous xamoterol in man.
Bowes RJ; Gautam PC; Graham DR; Harley A
Eur J Clin Pharmacol; 1986; 29(6):731-4. PubMed ID: 2872057
[TBL] [Abstract][Full Text] [Related]
18. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
19. Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol.
Jennings G; Bobik A; Oddie C; Restall R
Clin Pharmacol Ther; 1984 May; 35(5):594-603. PubMed ID: 6143634
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol.
Mehlsen J; Trap-Jensen J
Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
